Global Morphine Sulphate Market Growth 2026-2032
The global Morphine Sulphate market size is predicted to grow from US$ 3228 million in 2025 to US$ 4107 million in 2032; it is expected to grow at a CAGR of 3.5% from 2026 to 2032.
In 2025, global Morphine Sulphate output reached about 11 billion dosage units and global capacity of around 12 billion dosage units. The average price is about USD 0.30 per dosage unit, with gross margins near 45%. Morphine Sulphate is a pharmaceutical-grade opioid analgesic produced by reacting purified morphine base, which is primarily extracted from the opium poppy (Papaver somniferum), with sulfuric acid to form the sulfate salt. It is widely used for the management of moderate to severe acute and chronic pain in hospitals, palliative care, postoperative treatment, trauma care, and cancer pain management. The Morphine Sulphate supply chain begins upstream with licensed cultivation of opium poppies, extraction of opium alkaloids, purification of morphine base, and procurement of pharmaceutical excipients, sulfuric acid, and packaging materials. Midstream activities include morphine sulfate synthesis, formulation into injectable solutions, tablets, capsules, oral solutions, or sustained-release dosage forms, followed by sterile manufacturing where applicable, quality control, regulatory compliance, and GMP-certified packaging. Downstream, the finished products are distributed through tightly regulated pharmaceutical wholesalers, hospital pharmacies, retail pharmacies, government healthcare systems, and palliative care providers, with strict controlled-substance regulations governing production, transportation, storage, prescribing, and dispensing throughout the entire supply chain.
The Morphine Sulphate market is growing steadily due to the increasing prevalence of cancer, postoperative pain, trauma injuries, and chronic diseases requiring effective pain management, together with the expanding elderly population that is more susceptible to severe pain conditions. Rising demand for palliative care, hospice services, and improved access to essential pain medicines in emerging economies is further supporting market expansion. Growth is also driven by increasing surgical procedures, greater availability of controlled-release and abuse-deterrent formulations, and ongoing improvements in hospital pain-management protocols. In addition, government efforts and international health organizations to improve access to opioid analgesics for legitimate medical use, particularly in low- and middle-income countries where access has historically been limited, are creating new opportunities. Although stringent regulations, opioid misuse concerns, and prescription monitoring programs restrain growth in some developed markets, continued demand for medically supervised pain relief, coupled with investments in secure manufacturing, supply-chain traceability, and regulatory compliance, is expected to sustain long-term market development.
LP Information, Inc. (LPI) ' newest research report, the “Morphine Sulphate Industry Forecast” looks at past sales and reviews total world Morphine Sulphate sales in 2025, providing a comprehensive analysis by region and market sector of projected Morphine Sulphate sales for 2026 through 2032. With Morphine Sulphate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Morphine Sulphate industry.
This Insight Report provides a comprehensive analysis of the global Morphine Sulphate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Morphine Sulphate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Morphine Sulphate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Morphine Sulphate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Morphine Sulphate.
This report presents a comprehensive overview, market shares, and growth opportunities of Morphine Sulphate market by product type, application, key manufacturers and key regions and countries.
In 2025, global Morphine Sulphate output reached about 11 billion dosage units and global capacity of around 12 billion dosage units. The average price is about USD 0.30 per dosage unit, with gross margins near 45%. Morphine Sulphate is a pharmaceutical-grade opioid analgesic produced by reacting purified morphine base, which is primarily extracted from the opium poppy (Papaver somniferum), with sulfuric acid to form the sulfate salt. It is widely used for the management of moderate to severe acute and chronic pain in hospitals, palliative care, postoperative treatment, trauma care, and cancer pain management. The Morphine Sulphate supply chain begins upstream with licensed cultivation of opium poppies, extraction of opium alkaloids, purification of morphine base, and procurement of pharmaceutical excipients, sulfuric acid, and packaging materials. Midstream activities include morphine sulfate synthesis, formulation into injectable solutions, tablets, capsules, oral solutions, or sustained-release dosage forms, followed by sterile manufacturing where applicable, quality control, regulatory compliance, and GMP-certified packaging. Downstream, the finished products are distributed through tightly regulated pharmaceutical wholesalers, hospital pharmacies, retail pharmacies, government healthcare systems, and palliative care providers, with strict controlled-substance regulations governing production, transportation, storage, prescribing, and dispensing throughout the entire supply chain.
The Morphine Sulphate market is growing steadily due to the increasing prevalence of cancer, postoperative pain, trauma injuries, and chronic diseases requiring effective pain management, together with the expanding elderly population that is more susceptible to severe pain conditions. Rising demand for palliative care, hospice services, and improved access to essential pain medicines in emerging economies is further supporting market expansion. Growth is also driven by increasing surgical procedures, greater availability of controlled-release and abuse-deterrent formulations, and ongoing improvements in hospital pain-management protocols. In addition, government efforts and international health organizations to improve access to opioid analgesics for legitimate medical use, particularly in low- and middle-income countries where access has historically been limited, are creating new opportunities. Although stringent regulations, opioid misuse concerns, and prescription monitoring programs restrain growth in some developed markets, continued demand for medically supervised pain relief, coupled with investments in secure manufacturing, supply-chain traceability, and regulatory compliance, is expected to sustain long-term market development.
LP Information, Inc. (LPI) ' newest research report, the “Morphine Sulphate Industry Forecast” looks at past sales and reviews total world Morphine Sulphate sales in 2025, providing a comprehensive analysis by region and market sector of projected Morphine Sulphate sales for 2026 through 2032. With Morphine Sulphate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Morphine Sulphate industry.
This Insight Report provides a comprehensive analysis of the global Morphine Sulphate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Morphine Sulphate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Morphine Sulphate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Morphine Sulphate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Morphine Sulphate.
This report presents a comprehensive overview, market shares, and growth opportunities of Morphine Sulphate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immediate-Release (IR)
- Controlled-Release (CR)
- Sustained-Release (SR)
Segmentation by Strength:
- <15 mg
- 15–30 mg
- 30–60 mg
- 60–100 mg
- >100 mg
Segmentation by Sterility:
- Sterile Injectable Grade
- Non-Sterile Oral Grade
Segmentation by Application:
- Acute Pain Management
- Chronic Pain Management
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jiangsu Nhwa Pharmaceutical
- Humanwell Healthcare Group
- Mallinckrodt Pharmaceuticals
- Hikma Pharmaceuticals
- Viatris
- Pfizer
- Fresenius Kabi
- Hameln Pharma
- Teva Pharmaceutical
- Sun Pharmaceutical
- Amneal Pharmaceuticals
- Rhodes Pharmaceuticals
- Purdue Pharma
- Sandoz
- Alcaliber
- Tasmanian Alkaloids
- G.L. Pharma
- Martindale Pharma
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Morphine Sulphate market?
- What factors are driving Morphine Sulphate market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Morphine Sulphate market opportunities vary by end market size?
- How does Morphine Sulphate break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Morphine Sulphate Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Morphine Sulphate by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Morphine Sulphate by Country/Region, 2021, 2025 & 2032
2.2 Morphine Sulphate Segment by Type
2.2.1 Immediate-Release (IR)
2.2.2 Controlled-Release (CR)
2.2.3 Sustained-Release (SR)
2.2.4 Morphine Sulphate Sales by Type
2.2.4.1 Global Morphine Sulphate Sales Market Share by Type (2021-2026)
2.2.4.2 Global Morphine Sulphate Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Morphine Sulphate Sale Price by Type (2021-2026)
2.3 Morphine Sulphate Segment by Strength
2.3.1 <15 mg
2.3.2 15–30 mg
2.3.3 30–60 mg
2.3.4 60–100 mg
2.3.5 >100 mg
2.3.6 Morphine Sulphate Sales by Strength
2.3.6.1 Global Morphine Sulphate Sales Market Share by Strength (2021-2026)
2.3.6.2 Global Morphine Sulphate Revenue and Market Share by Strength (2021-2026)
2.3.6.3 Global Morphine Sulphate Sale Price by Strength (2021-2026)
2.4 Morphine Sulphate Segment by Sterility
2.4.1 Sterile Injectable Grade
2.4.2 Non-Sterile Oral Grade
2.4.3 Morphine Sulphate Sales by Sterility
2.4.3.1 Global Morphine Sulphate Sales Market Share by Sterility (2021-2026)
2.4.3.2 Global Morphine Sulphate Revenue and Market Share by Sterility (2021-2026)
2.4.3.3 Global Morphine Sulphate Sale Price by Sterility (2021-2026)
2.5 Morphine Sulphate Segment by Application
2.5.1 Acute Pain Management
2.5.2 Chronic Pain Management
2.5.3 Morphine Sulphate Sales by Application
2.5.3.1 Global Morphine Sulphate Sale Market Share by Application (2021-2026)
2.5.3.2 Global Morphine Sulphate Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Morphine Sulphate Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Morphine Sulphate Breakdown Data by Company
3.1.1 Global Morphine Sulphate Annual Sales by Company (2021-2026)
3.1.2 Global Morphine Sulphate Sales Market Share by Company (2021-2026)
3.2 Global Morphine Sulphate Annual Revenue by Company (2021-2026)
3.2.1 Global Morphine Sulphate Revenue by Company (2021-2026)
3.2.2 Global Morphine Sulphate Revenue Market Share by Company (2021-2026)
3.3 Global Morphine Sulphate Sale Price by Company
3.4 Key Manufacturers Morphine Sulphate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Morphine Sulphate Product Location Distribution
3.4.2 Players Morphine Sulphate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MORPHINE SULPHATE BY GEOGRAPHIC REGION
4.1 World Historic Morphine Sulphate Market Size by Geographic Region (2021-2026)
4.1.1 Global Morphine Sulphate Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Morphine Sulphate Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Morphine Sulphate Market Size by Country/Region (2021-2026)
4.2.1 Global Morphine Sulphate Annual Sales by Country/Region (2021-2026)
4.2.2 Global Morphine Sulphate Annual Revenue by Country/Region (2021-2026)
4.3 Americas Morphine Sulphate Sales Growth
4.4 APAC Morphine Sulphate Sales Growth
4.5 Europe Morphine Sulphate Sales Growth
4.6 Middle East & Africa Morphine Sulphate Sales Growth
5 AMERICAS
5.1 Americas Morphine Sulphate Sales by Country
5.1.1 Americas Morphine Sulphate Sales by Country (2021-2026)
5.1.2 Americas Morphine Sulphate Revenue by Country (2021-2026)
5.2 Americas Morphine Sulphate Sales by Type (2021-2026)
5.3 Americas Morphine Sulphate Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Morphine Sulphate Sales by Region
6.1.1 APAC Morphine Sulphate Sales by Region (2021-2026)
6.1.2 APAC Morphine Sulphate Revenue by Region (2021-2026)
6.2 APAC Morphine Sulphate Sales by Type (2021-2026)
6.3 APAC Morphine Sulphate Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Morphine Sulphate by Country
7.1.1 Europe Morphine Sulphate Sales by Country (2021-2026)
7.1.2 Europe Morphine Sulphate Revenue by Country (2021-2026)
7.2 Europe Morphine Sulphate Sales by Type (2021-2026)
7.3 Europe Morphine Sulphate Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Morphine Sulphate by Country
8.1.1 Middle East & Africa Morphine Sulphate Sales by Country (2021-2026)
8.1.2 Middle East & Africa Morphine Sulphate Revenue by Country (2021-2026)
8.2 Middle East & Africa Morphine Sulphate Sales by Type (2021-2026)
8.3 Middle East & Africa Morphine Sulphate Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Morphine Sulphate
10.3 Manufacturing Process Analysis of Morphine Sulphate
10.4 Industry Chain Structure of Morphine Sulphate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Morphine Sulphate Distributors
11.3 Morphine Sulphate Customer
12 WORLD FORECAST REVIEW FOR MORPHINE SULPHATE BY GEOGRAPHIC REGION
12.1 Global Morphine Sulphate Market Size Forecast by Region
12.1.1 Global Morphine Sulphate Forecast by Region (2027-2032)
12.1.2 Global Morphine Sulphate Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Morphine Sulphate Forecast by Type (2027-2032)
12.7 Global Morphine Sulphate Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Nhwa Pharmaceutical
13.1.1 Jiangsu Nhwa Pharmaceutical Company Information
13.1.2 Jiangsu Nhwa Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
13.1.3 Jiangsu Nhwa Pharmaceutical Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
13.1.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.2 Humanwell Healthcare Group
13.2.1 Humanwell Healthcare Group Company Information
13.2.2 Humanwell Healthcare Group Morphine Sulphate Product Portfolios and Specifications
13.2.3 Humanwell Healthcare Group Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Humanwell Healthcare Group Main Business Overview
13.2.5 Humanwell Healthcare Group Latest Developments
13.3 Mallinckrodt Pharmaceuticals
13.3.1 Mallinckrodt Pharmaceuticals Company Information
13.3.2 Mallinckrodt Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
13.3.3 Mallinckrodt Pharmaceuticals Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.3.5 Mallinckrodt Pharmaceuticals Latest Developments
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Information
13.4.2 Hikma Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
13.4.3 Hikma Pharmaceuticals Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hikma Pharmaceuticals Main Business Overview
13.4.5 Hikma Pharmaceuticals Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Morphine Sulphate Product Portfolios and Specifications
13.5.3 Viatris Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Morphine Sulphate Product Portfolios and Specifications
13.6.3 Pfizer Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Morphine Sulphate Product Portfolios and Specifications
13.7.3 Fresenius Kabi Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Hameln Pharma
13.8.1 Hameln Pharma Company Information
13.8.2 Hameln Pharma Morphine Sulphate Product Portfolios and Specifications
13.8.3 Hameln Pharma Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hameln Pharma Main Business Overview
13.8.5 Hameln Pharma Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Sun Pharmaceutical
13.10.1 Sun Pharmaceutical Company Information
13.10.2 Sun Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
13.10.3 Sun Pharmaceutical Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sun Pharmaceutical Main Business Overview
13.10.5 Sun Pharmaceutical Latest Developments
13.11 Amneal Pharmaceuticals
13.11.1 Amneal Pharmaceuticals Company Information
13.11.2 Amneal Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
13.11.3 Amneal Pharmaceuticals Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Amneal Pharmaceuticals Main Business Overview
13.11.5 Amneal Pharmaceuticals Latest Developments
13.12 Rhodes Pharmaceuticals
13.12.1 Rhodes Pharmaceuticals Company Information
13.12.2 Rhodes Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
13.12.3 Rhodes Pharmaceuticals Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Rhodes Pharmaceuticals Main Business Overview
13.12.5 Rhodes Pharmaceuticals Latest Developments
13.13 Purdue Pharma
13.13.1 Purdue Pharma Company Information
13.13.2 Purdue Pharma Morphine Sulphate Product Portfolios and Specifications
13.13.3 Purdue Pharma Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Purdue Pharma Main Business Overview
13.13.5 Purdue Pharma Latest Developments
13.14 Sandoz
13.14.1 Sandoz Company Information
13.14.2 Sandoz Morphine Sulphate Product Portfolios and Specifications
13.14.3 Sandoz Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sandoz Main Business Overview
13.14.5 Sandoz Latest Developments
13.15 Alcaliber
13.15.1 Alcaliber Company Information
13.15.2 Alcaliber Morphine Sulphate Product Portfolios and Specifications
13.15.3 Alcaliber Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Alcaliber Main Business Overview
13.15.5 Alcaliber Latest Developments
13.16 Tasmanian Alkaloids
13.16.1 Tasmanian Alkaloids Company Information
13.16.2 Tasmanian Alkaloids Morphine Sulphate Product Portfolios and Specifications
13.16.3 Tasmanian Alkaloids Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Tasmanian Alkaloids Main Business Overview
13.16.5 Tasmanian Alkaloids Latest Developments
13.17 G.L. Pharma
13.17.1 G.L. Pharma Company Information
13.17.2 G.L. Pharma Morphine Sulphate Product Portfolios and Specifications
13.17.3 G.L. Pharma Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 G.L. Pharma Main Business Overview
13.17.5 G.L. Pharma Latest Developments
13.18 Martindale Pharma
13.18.1 Martindale Pharma Company Information
13.18.2 Martindale Pharma Morphine Sulphate Product Portfolios and Specifications
13.18.3 Martindale Pharma Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Martindale Pharma Main Business Overview
13.18.5 Martindale Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Morphine Sulphate Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Morphine Sulphate by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Morphine Sulphate by Country/Region, 2021, 2025 & 2032
2.2 Morphine Sulphate Segment by Type
2.2.1 Immediate-Release (IR)
2.2.2 Controlled-Release (CR)
2.2.3 Sustained-Release (SR)
2.2.4 Morphine Sulphate Sales by Type
2.2.4.1 Global Morphine Sulphate Sales Market Share by Type (2021-2026)
2.2.4.2 Global Morphine Sulphate Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Morphine Sulphate Sale Price by Type (2021-2026)
2.3 Morphine Sulphate Segment by Strength
2.3.1 <15 mg
2.3.2 15–30 mg
2.3.3 30–60 mg
2.3.4 60–100 mg
2.3.5 >100 mg
2.3.6 Morphine Sulphate Sales by Strength
2.3.6.1 Global Morphine Sulphate Sales Market Share by Strength (2021-2026)
2.3.6.2 Global Morphine Sulphate Revenue and Market Share by Strength (2021-2026)
2.3.6.3 Global Morphine Sulphate Sale Price by Strength (2021-2026)
2.4 Morphine Sulphate Segment by Sterility
2.4.1 Sterile Injectable Grade
2.4.2 Non-Sterile Oral Grade
2.4.3 Morphine Sulphate Sales by Sterility
2.4.3.1 Global Morphine Sulphate Sales Market Share by Sterility (2021-2026)
2.4.3.2 Global Morphine Sulphate Revenue and Market Share by Sterility (2021-2026)
2.4.3.3 Global Morphine Sulphate Sale Price by Sterility (2021-2026)
2.5 Morphine Sulphate Segment by Application
2.5.1 Acute Pain Management
2.5.2 Chronic Pain Management
2.5.3 Morphine Sulphate Sales by Application
2.5.3.1 Global Morphine Sulphate Sale Market Share by Application (2021-2026)
2.5.3.2 Global Morphine Sulphate Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Morphine Sulphate Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Morphine Sulphate Breakdown Data by Company
3.1.1 Global Morphine Sulphate Annual Sales by Company (2021-2026)
3.1.2 Global Morphine Sulphate Sales Market Share by Company (2021-2026)
3.2 Global Morphine Sulphate Annual Revenue by Company (2021-2026)
3.2.1 Global Morphine Sulphate Revenue by Company (2021-2026)
3.2.2 Global Morphine Sulphate Revenue Market Share by Company (2021-2026)
3.3 Global Morphine Sulphate Sale Price by Company
3.4 Key Manufacturers Morphine Sulphate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Morphine Sulphate Product Location Distribution
3.4.2 Players Morphine Sulphate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MORPHINE SULPHATE BY GEOGRAPHIC REGION
4.1 World Historic Morphine Sulphate Market Size by Geographic Region (2021-2026)
4.1.1 Global Morphine Sulphate Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Morphine Sulphate Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Morphine Sulphate Market Size by Country/Region (2021-2026)
4.2.1 Global Morphine Sulphate Annual Sales by Country/Region (2021-2026)
4.2.2 Global Morphine Sulphate Annual Revenue by Country/Region (2021-2026)
4.3 Americas Morphine Sulphate Sales Growth
4.4 APAC Morphine Sulphate Sales Growth
4.5 Europe Morphine Sulphate Sales Growth
4.6 Middle East & Africa Morphine Sulphate Sales Growth
5 AMERICAS
5.1 Americas Morphine Sulphate Sales by Country
5.1.1 Americas Morphine Sulphate Sales by Country (2021-2026)
5.1.2 Americas Morphine Sulphate Revenue by Country (2021-2026)
5.2 Americas Morphine Sulphate Sales by Type (2021-2026)
5.3 Americas Morphine Sulphate Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Morphine Sulphate Sales by Region
6.1.1 APAC Morphine Sulphate Sales by Region (2021-2026)
6.1.2 APAC Morphine Sulphate Revenue by Region (2021-2026)
6.2 APAC Morphine Sulphate Sales by Type (2021-2026)
6.3 APAC Morphine Sulphate Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Morphine Sulphate by Country
7.1.1 Europe Morphine Sulphate Sales by Country (2021-2026)
7.1.2 Europe Morphine Sulphate Revenue by Country (2021-2026)
7.2 Europe Morphine Sulphate Sales by Type (2021-2026)
7.3 Europe Morphine Sulphate Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Morphine Sulphate by Country
8.1.1 Middle East & Africa Morphine Sulphate Sales by Country (2021-2026)
8.1.2 Middle East & Africa Morphine Sulphate Revenue by Country (2021-2026)
8.2 Middle East & Africa Morphine Sulphate Sales by Type (2021-2026)
8.3 Middle East & Africa Morphine Sulphate Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Morphine Sulphate
10.3 Manufacturing Process Analysis of Morphine Sulphate
10.4 Industry Chain Structure of Morphine Sulphate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Morphine Sulphate Distributors
11.3 Morphine Sulphate Customer
12 WORLD FORECAST REVIEW FOR MORPHINE SULPHATE BY GEOGRAPHIC REGION
12.1 Global Morphine Sulphate Market Size Forecast by Region
12.1.1 Global Morphine Sulphate Forecast by Region (2027-2032)
12.1.2 Global Morphine Sulphate Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Morphine Sulphate Forecast by Type (2027-2032)
12.7 Global Morphine Sulphate Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Nhwa Pharmaceutical
13.1.1 Jiangsu Nhwa Pharmaceutical Company Information
13.1.2 Jiangsu Nhwa Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
13.1.3 Jiangsu Nhwa Pharmaceutical Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
13.1.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.2 Humanwell Healthcare Group
13.2.1 Humanwell Healthcare Group Company Information
13.2.2 Humanwell Healthcare Group Morphine Sulphate Product Portfolios and Specifications
13.2.3 Humanwell Healthcare Group Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Humanwell Healthcare Group Main Business Overview
13.2.5 Humanwell Healthcare Group Latest Developments
13.3 Mallinckrodt Pharmaceuticals
13.3.1 Mallinckrodt Pharmaceuticals Company Information
13.3.2 Mallinckrodt Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
13.3.3 Mallinckrodt Pharmaceuticals Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.3.5 Mallinckrodt Pharmaceuticals Latest Developments
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Information
13.4.2 Hikma Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
13.4.3 Hikma Pharmaceuticals Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hikma Pharmaceuticals Main Business Overview
13.4.5 Hikma Pharmaceuticals Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Morphine Sulphate Product Portfolios and Specifications
13.5.3 Viatris Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Morphine Sulphate Product Portfolios and Specifications
13.6.3 Pfizer Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Morphine Sulphate Product Portfolios and Specifications
13.7.3 Fresenius Kabi Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Hameln Pharma
13.8.1 Hameln Pharma Company Information
13.8.2 Hameln Pharma Morphine Sulphate Product Portfolios and Specifications
13.8.3 Hameln Pharma Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hameln Pharma Main Business Overview
13.8.5 Hameln Pharma Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Sun Pharmaceutical
13.10.1 Sun Pharmaceutical Company Information
13.10.2 Sun Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
13.10.3 Sun Pharmaceutical Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sun Pharmaceutical Main Business Overview
13.10.5 Sun Pharmaceutical Latest Developments
13.11 Amneal Pharmaceuticals
13.11.1 Amneal Pharmaceuticals Company Information
13.11.2 Amneal Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
13.11.3 Amneal Pharmaceuticals Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Amneal Pharmaceuticals Main Business Overview
13.11.5 Amneal Pharmaceuticals Latest Developments
13.12 Rhodes Pharmaceuticals
13.12.1 Rhodes Pharmaceuticals Company Information
13.12.2 Rhodes Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
13.12.3 Rhodes Pharmaceuticals Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Rhodes Pharmaceuticals Main Business Overview
13.12.5 Rhodes Pharmaceuticals Latest Developments
13.13 Purdue Pharma
13.13.1 Purdue Pharma Company Information
13.13.2 Purdue Pharma Morphine Sulphate Product Portfolios and Specifications
13.13.3 Purdue Pharma Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Purdue Pharma Main Business Overview
13.13.5 Purdue Pharma Latest Developments
13.14 Sandoz
13.14.1 Sandoz Company Information
13.14.2 Sandoz Morphine Sulphate Product Portfolios and Specifications
13.14.3 Sandoz Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sandoz Main Business Overview
13.14.5 Sandoz Latest Developments
13.15 Alcaliber
13.15.1 Alcaliber Company Information
13.15.2 Alcaliber Morphine Sulphate Product Portfolios and Specifications
13.15.3 Alcaliber Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Alcaliber Main Business Overview
13.15.5 Alcaliber Latest Developments
13.16 Tasmanian Alkaloids
13.16.1 Tasmanian Alkaloids Company Information
13.16.2 Tasmanian Alkaloids Morphine Sulphate Product Portfolios and Specifications
13.16.3 Tasmanian Alkaloids Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Tasmanian Alkaloids Main Business Overview
13.16.5 Tasmanian Alkaloids Latest Developments
13.17 G.L. Pharma
13.17.1 G.L. Pharma Company Information
13.17.2 G.L. Pharma Morphine Sulphate Product Portfolios and Specifications
13.17.3 G.L. Pharma Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 G.L. Pharma Main Business Overview
13.17.5 G.L. Pharma Latest Developments
13.18 Martindale Pharma
13.18.1 Martindale Pharma Company Information
13.18.2 Martindale Pharma Morphine Sulphate Product Portfolios and Specifications
13.18.3 Martindale Pharma Morphine Sulphate Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Martindale Pharma Main Business Overview
13.18.5 Martindale Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Morphine Sulphate Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Morphine Sulphate Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immediate-Release (IR)
Table 4. Major Players of Controlled-Release (CR)
Table 5. Major Players of Sustained-Release (SR)
Table 6. Global Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 7. Global Morphine Sulphate Sales Market Share by Type (2021-2026)
Table 8. Global Morphine Sulphate Revenue by Type (2021-2026) & ($ million)
Table 9. Global Morphine Sulphate Revenue Market Share by Type (2021-2026)
Table 10. Global Morphine Sulphate Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of <15 mg
Table 12. Major Players of 15–30 mg
Table 13. Major Players of 30–60 mg
Table 14. Major Players of 60–100 mg
Table 15. Major Players of >100 mg
Table 16. Global Morphine Sulphate Sales by Strength (2021-2026) & (K Units)
Table 17. Global Morphine Sulphate Sales Market Share by Strength (2021-2026)
Table 18. Global Morphine Sulphate Revenue by Strength (2021-2026) & ($ million)
Table 19. Global Morphine Sulphate Revenue Market Share by Strength (2021-2026)
Table 20. Global Morphine Sulphate Sale Price by Strength (2021-2026) & (US$/Unit)
Table 21. Major Players of Sterile Injectable Grade
Table 22. Major Players of Non-Sterile Oral Grade
Table 23. Global Morphine Sulphate Sales by Sterility (2021-2026) & (K Units)
Table 24. Global Morphine Sulphate Sales Market Share by Sterility (2021-2026)
Table 25. Global Morphine Sulphate Revenue by Sterility (2021-2026) & ($ million)
Table 26. Global Morphine Sulphate Revenue Market Share by Sterility (2021-2026)
Table 27. Global Morphine Sulphate Sale Price by Sterility (2021-2026) & (US$/Unit)
Table 28. Global Morphine Sulphate Sale by Application (2021-2026) & (K Units)
Table 29. Global Morphine Sulphate Sale Market Share by Application (2021-2026)
Table 30. Global Morphine Sulphate Revenue by Application (2021-2026) & ($ million)
Table 31. Global Morphine Sulphate Revenue Market Share by Application (2021-2026)
Table 32. Global Morphine Sulphate Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global Morphine Sulphate Sales by Company (2021-2026) & (K Units)
Table 34. Global Morphine Sulphate Sales Market Share by Company (2021-2026)
Table 35. Global Morphine Sulphate Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Morphine Sulphate Revenue Market Share by Company (2021-2026)
Table 37. Global Morphine Sulphate Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers Morphine Sulphate Producing Area Distribution and Sales Area
Table 39. Players Morphine Sulphate Products Offered
Table 40. Morphine Sulphate Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Morphine Sulphate Sales by Geographic Region (2021-2026) & (K Units)
Table 44. Global Morphine Sulphate Sales Market Share Geographic Region (2021-2026)
Table 45. Global Morphine Sulphate Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Morphine Sulphate Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Morphine Sulphate Sales by Country/Region (2021-2026) & (K Units)
Table 48. Global Morphine Sulphate Sales Market Share by Country/Region (2021-2026)
Table 49. Global Morphine Sulphate Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Morphine Sulphate Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Morphine Sulphate Sales by Country (2021-2026) & (K Units)
Table 52. Americas Morphine Sulphate Sales Market Share by Country (2021-2026)
Table 53. Americas Morphine Sulphate Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 55. Americas Morphine Sulphate Sales by Application (2021-2026) & (K Units)
Table 56. APAC Morphine Sulphate Sales by Region (2021-2026) & (K Units)
Table 57. APAC Morphine Sulphate Sales Market Share by Region (2021-2026)
Table 58. APAC Morphine Sulphate Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 60. APAC Morphine Sulphate Sales by Application (2021-2026) & (K Units)
Table 61. Europe Morphine Sulphate Sales by Country (2021-2026) & (K Units)
Table 62. Europe Morphine Sulphate Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 64. Europe Morphine Sulphate Sales by Application (2021-2026) & (K Units)
Table 65. Middle East & Africa Morphine Sulphate Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Morphine Sulphate Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa Morphine Sulphate Sales by Application (2021-2026) & (K Units)
Table 69. Key Market Drivers & Growth Opportunities of Morphine Sulphate
Table 70. Key Market Challenges & Risks of Morphine Sulphate
Table 71. Key Industry Trends of Morphine Sulphate
Table 72. Morphine Sulphate Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Morphine Sulphate Distributors List
Table 75. Morphine Sulphate Customer List
Table 76. Global Morphine Sulphate Sales Forecast by Region (2027-2032) & (K Units)
Table 77. Global Morphine Sulphate Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Morphine Sulphate Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Americas Morphine Sulphate Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Morphine Sulphate Sales Forecast by Region (2027-2032) & (K Units)
Table 81. APAC Morphine Sulphate Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Morphine Sulphate Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Europe Morphine Sulphate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Morphine Sulphate Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Middle East & Africa Morphine Sulphate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Morphine Sulphate Sales Forecast by Type (2027-2032) & (K Units)
Table 87. Global Morphine Sulphate Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Morphine Sulphate Sales Forecast by Application (2027-2032) & (K Units)
Table 89. Global Morphine Sulphate Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Jiangsu Nhwa Pharmaceutical Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 91. Jiangsu Nhwa Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
Table 92. Jiangsu Nhwa Pharmaceutical Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Jiangsu Nhwa Pharmaceutical Main Business
Table 94. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 95. Humanwell Healthcare Group Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 96. Humanwell Healthcare Group Morphine Sulphate Product Portfolios and Specifications
Table 97. Humanwell Healthcare Group Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Humanwell Healthcare Group Main Business
Table 99. Humanwell Healthcare Group Latest Developments
Table 100. Mallinckrodt Pharmaceuticals Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 101. Mallinckrodt Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
Table 102. Mallinckrodt Pharmaceuticals Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Mallinckrodt Pharmaceuticals Main Business
Table 104. Mallinckrodt Pharmaceuticals Latest Developments
Table 105. Hikma Pharmaceuticals Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 106. Hikma Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
Table 107. Hikma Pharmaceuticals Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Hikma Pharmaceuticals Main Business
Table 109. Hikma Pharmaceuticals Latest Developments
Table 110. Viatris Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 111. Viatris Morphine Sulphate Product Portfolios and Specifications
Table 112. Viatris Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Viatris Main Business
Table 114. Viatris Latest Developments
Table 115. Pfizer Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Morphine Sulphate Product Portfolios and Specifications
Table 117. Pfizer Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. Fresenius Kabi Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 121. Fresenius Kabi Morphine Sulphate Product Portfolios and Specifications
Table 122. Fresenius Kabi Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Fresenius Kabi Main Business
Table 124. Fresenius Kabi Latest Developments
Table 125. Hameln Pharma Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 126. Hameln Pharma Morphine Sulphate Product Portfolios and Specifications
Table 127. Hameln Pharma Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Hameln Pharma Main Business
Table 129. Hameln Pharma Latest Developments
Table 130. Teva Pharmaceutical Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 131. Teva Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
Table 132. Teva Pharmaceutical Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Teva Pharmaceutical Main Business
Table 134. Teva Pharmaceutical Latest Developments
Table 135. Sun Pharmaceutical Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 136. Sun Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
Table 137. Sun Pharmaceutical Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Sun Pharmaceutical Main Business
Table 139. Sun Pharmaceutical Latest Developments
Table 140. Amneal Pharmaceuticals Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 141. Amneal Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
Table 142. Amneal Pharmaceuticals Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Amneal Pharmaceuticals Main Business
Table 144. Amneal Pharmaceuticals Latest Developments
Table 145. Rhodes Pharmaceuticals Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 146. Rhodes Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
Table 147. Rhodes Pharmaceuticals Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Rhodes Pharmaceuticals Main Business
Table 149. Rhodes Pharmaceuticals Latest Developments
Table 150. Purdue Pharma Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 151. Purdue Pharma Morphine Sulphate Product Portfolios and Specifications
Table 152. Purdue Pharma Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Purdue Pharma Main Business
Table 154. Purdue Pharma Latest Developments
Table 155. Sandoz Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 156. Sandoz Morphine Sulphate Product Portfolios and Specifications
Table 157. Sandoz Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Sandoz Main Business
Table 159. Sandoz Latest Developments
Table 160. Alcaliber Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 161. Alcaliber Morphine Sulphate Product Portfolios and Specifications
Table 162. Alcaliber Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Alcaliber Main Business
Table 164. Alcaliber Latest Developments
Table 165. Tasmanian Alkaloids Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 166. Tasmanian Alkaloids Morphine Sulphate Product Portfolios and Specifications
Table 167. Tasmanian Alkaloids Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Tasmanian Alkaloids Main Business
Table 169. Tasmanian Alkaloids Latest Developments
Table 170. G.L. Pharma Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 171. G.L. Pharma Morphine Sulphate Product Portfolios and Specifications
Table 172. G.L. Pharma Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. G.L. Pharma Main Business
Table 174. G.L. Pharma Latest Developments
Table 175. Martindale Pharma Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 176. Martindale Pharma Morphine Sulphate Product Portfolios and Specifications
Table 177. Martindale Pharma Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Martindale Pharma Main Business
Table 179. Martindale Pharma Latest Developments
Table 1. Morphine Sulphate Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Morphine Sulphate Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immediate-Release (IR)
Table 4. Major Players of Controlled-Release (CR)
Table 5. Major Players of Sustained-Release (SR)
Table 6. Global Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 7. Global Morphine Sulphate Sales Market Share by Type (2021-2026)
Table 8. Global Morphine Sulphate Revenue by Type (2021-2026) & ($ million)
Table 9. Global Morphine Sulphate Revenue Market Share by Type (2021-2026)
Table 10. Global Morphine Sulphate Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of <15 mg
Table 12. Major Players of 15–30 mg
Table 13. Major Players of 30–60 mg
Table 14. Major Players of 60–100 mg
Table 15. Major Players of >100 mg
Table 16. Global Morphine Sulphate Sales by Strength (2021-2026) & (K Units)
Table 17. Global Morphine Sulphate Sales Market Share by Strength (2021-2026)
Table 18. Global Morphine Sulphate Revenue by Strength (2021-2026) & ($ million)
Table 19. Global Morphine Sulphate Revenue Market Share by Strength (2021-2026)
Table 20. Global Morphine Sulphate Sale Price by Strength (2021-2026) & (US$/Unit)
Table 21. Major Players of Sterile Injectable Grade
Table 22. Major Players of Non-Sterile Oral Grade
Table 23. Global Morphine Sulphate Sales by Sterility (2021-2026) & (K Units)
Table 24. Global Morphine Sulphate Sales Market Share by Sterility (2021-2026)
Table 25. Global Morphine Sulphate Revenue by Sterility (2021-2026) & ($ million)
Table 26. Global Morphine Sulphate Revenue Market Share by Sterility (2021-2026)
Table 27. Global Morphine Sulphate Sale Price by Sterility (2021-2026) & (US$/Unit)
Table 28. Global Morphine Sulphate Sale by Application (2021-2026) & (K Units)
Table 29. Global Morphine Sulphate Sale Market Share by Application (2021-2026)
Table 30. Global Morphine Sulphate Revenue by Application (2021-2026) & ($ million)
Table 31. Global Morphine Sulphate Revenue Market Share by Application (2021-2026)
Table 32. Global Morphine Sulphate Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global Morphine Sulphate Sales by Company (2021-2026) & (K Units)
Table 34. Global Morphine Sulphate Sales Market Share by Company (2021-2026)
Table 35. Global Morphine Sulphate Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Morphine Sulphate Revenue Market Share by Company (2021-2026)
Table 37. Global Morphine Sulphate Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers Morphine Sulphate Producing Area Distribution and Sales Area
Table 39. Players Morphine Sulphate Products Offered
Table 40. Morphine Sulphate Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Morphine Sulphate Sales by Geographic Region (2021-2026) & (K Units)
Table 44. Global Morphine Sulphate Sales Market Share Geographic Region (2021-2026)
Table 45. Global Morphine Sulphate Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Morphine Sulphate Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Morphine Sulphate Sales by Country/Region (2021-2026) & (K Units)
Table 48. Global Morphine Sulphate Sales Market Share by Country/Region (2021-2026)
Table 49. Global Morphine Sulphate Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Morphine Sulphate Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Morphine Sulphate Sales by Country (2021-2026) & (K Units)
Table 52. Americas Morphine Sulphate Sales Market Share by Country (2021-2026)
Table 53. Americas Morphine Sulphate Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 55. Americas Morphine Sulphate Sales by Application (2021-2026) & (K Units)
Table 56. APAC Morphine Sulphate Sales by Region (2021-2026) & (K Units)
Table 57. APAC Morphine Sulphate Sales Market Share by Region (2021-2026)
Table 58. APAC Morphine Sulphate Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 60. APAC Morphine Sulphate Sales by Application (2021-2026) & (K Units)
Table 61. Europe Morphine Sulphate Sales by Country (2021-2026) & (K Units)
Table 62. Europe Morphine Sulphate Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 64. Europe Morphine Sulphate Sales by Application (2021-2026) & (K Units)
Table 65. Middle East & Africa Morphine Sulphate Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Morphine Sulphate Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Morphine Sulphate Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa Morphine Sulphate Sales by Application (2021-2026) & (K Units)
Table 69. Key Market Drivers & Growth Opportunities of Morphine Sulphate
Table 70. Key Market Challenges & Risks of Morphine Sulphate
Table 71. Key Industry Trends of Morphine Sulphate
Table 72. Morphine Sulphate Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Morphine Sulphate Distributors List
Table 75. Morphine Sulphate Customer List
Table 76. Global Morphine Sulphate Sales Forecast by Region (2027-2032) & (K Units)
Table 77. Global Morphine Sulphate Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Morphine Sulphate Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Americas Morphine Sulphate Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Morphine Sulphate Sales Forecast by Region (2027-2032) & (K Units)
Table 81. APAC Morphine Sulphate Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Morphine Sulphate Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Europe Morphine Sulphate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Morphine Sulphate Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Middle East & Africa Morphine Sulphate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Morphine Sulphate Sales Forecast by Type (2027-2032) & (K Units)
Table 87. Global Morphine Sulphate Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Morphine Sulphate Sales Forecast by Application (2027-2032) & (K Units)
Table 89. Global Morphine Sulphate Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Jiangsu Nhwa Pharmaceutical Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 91. Jiangsu Nhwa Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
Table 92. Jiangsu Nhwa Pharmaceutical Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Jiangsu Nhwa Pharmaceutical Main Business
Table 94. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 95. Humanwell Healthcare Group Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 96. Humanwell Healthcare Group Morphine Sulphate Product Portfolios and Specifications
Table 97. Humanwell Healthcare Group Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Humanwell Healthcare Group Main Business
Table 99. Humanwell Healthcare Group Latest Developments
Table 100. Mallinckrodt Pharmaceuticals Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 101. Mallinckrodt Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
Table 102. Mallinckrodt Pharmaceuticals Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Mallinckrodt Pharmaceuticals Main Business
Table 104. Mallinckrodt Pharmaceuticals Latest Developments
Table 105. Hikma Pharmaceuticals Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 106. Hikma Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
Table 107. Hikma Pharmaceuticals Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Hikma Pharmaceuticals Main Business
Table 109. Hikma Pharmaceuticals Latest Developments
Table 110. Viatris Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 111. Viatris Morphine Sulphate Product Portfolios and Specifications
Table 112. Viatris Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Viatris Main Business
Table 114. Viatris Latest Developments
Table 115. Pfizer Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Morphine Sulphate Product Portfolios and Specifications
Table 117. Pfizer Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. Fresenius Kabi Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 121. Fresenius Kabi Morphine Sulphate Product Portfolios and Specifications
Table 122. Fresenius Kabi Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Fresenius Kabi Main Business
Table 124. Fresenius Kabi Latest Developments
Table 125. Hameln Pharma Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 126. Hameln Pharma Morphine Sulphate Product Portfolios and Specifications
Table 127. Hameln Pharma Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Hameln Pharma Main Business
Table 129. Hameln Pharma Latest Developments
Table 130. Teva Pharmaceutical Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 131. Teva Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
Table 132. Teva Pharmaceutical Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Teva Pharmaceutical Main Business
Table 134. Teva Pharmaceutical Latest Developments
Table 135. Sun Pharmaceutical Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 136. Sun Pharmaceutical Morphine Sulphate Product Portfolios and Specifications
Table 137. Sun Pharmaceutical Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Sun Pharmaceutical Main Business
Table 139. Sun Pharmaceutical Latest Developments
Table 140. Amneal Pharmaceuticals Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 141. Amneal Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
Table 142. Amneal Pharmaceuticals Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Amneal Pharmaceuticals Main Business
Table 144. Amneal Pharmaceuticals Latest Developments
Table 145. Rhodes Pharmaceuticals Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 146. Rhodes Pharmaceuticals Morphine Sulphate Product Portfolios and Specifications
Table 147. Rhodes Pharmaceuticals Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Rhodes Pharmaceuticals Main Business
Table 149. Rhodes Pharmaceuticals Latest Developments
Table 150. Purdue Pharma Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 151. Purdue Pharma Morphine Sulphate Product Portfolios and Specifications
Table 152. Purdue Pharma Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Purdue Pharma Main Business
Table 154. Purdue Pharma Latest Developments
Table 155. Sandoz Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 156. Sandoz Morphine Sulphate Product Portfolios and Specifications
Table 157. Sandoz Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Sandoz Main Business
Table 159. Sandoz Latest Developments
Table 160. Alcaliber Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 161. Alcaliber Morphine Sulphate Product Portfolios and Specifications
Table 162. Alcaliber Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Alcaliber Main Business
Table 164. Alcaliber Latest Developments
Table 165. Tasmanian Alkaloids Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 166. Tasmanian Alkaloids Morphine Sulphate Product Portfolios and Specifications
Table 167. Tasmanian Alkaloids Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Tasmanian Alkaloids Main Business
Table 169. Tasmanian Alkaloids Latest Developments
Table 170. G.L. Pharma Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 171. G.L. Pharma Morphine Sulphate Product Portfolios and Specifications
Table 172. G.L. Pharma Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. G.L. Pharma Main Business
Table 174. G.L. Pharma Latest Developments
Table 175. Martindale Pharma Basic Information, Morphine Sulphate Manufacturing Base, Sales Area and Its Competitors
Table 176. Martindale Pharma Morphine Sulphate Product Portfolios and Specifications
Table 177. Martindale Pharma Morphine Sulphate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Martindale Pharma Main Business
Table 179. Martindale Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Morphine Sulphate
Figure 2. Morphine Sulphate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Morphine Sulphate Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Morphine Sulphate Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Morphine Sulphate Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Morphine Sulphate Sales Market Share by Country/Region (2025)
Figure 10. Morphine Sulphate Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immediate-Release (IR)
Figure 12. Product Picture of Controlled-Release (CR)
Figure 13. Product Picture of Sustained-Release (SR)
Figure 14. Global Morphine Sulphate Sales Market Share by Type in 2026
Figure 15. Global Morphine Sulphate Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of <15 mg
Figure 17. Product Picture of 15–30 mg
Figure 18. Product Picture of 30–60 mg
Figure 19. Product Picture of 60–100 mg
Figure 20. Product Picture of >100 mg
Figure 21. Global Morphine Sulphate Sales Market Share by Strength in 2026
Figure 22. Global Morphine Sulphate Revenue Market Share by Strength (2021-2026)
Figure 23. Product Picture of Sterile Injectable Grade
Figure 24. Product Picture of Non-Sterile Oral Grade
Figure 25. Global Morphine Sulphate Sales Market Share by Sterility in 2026
Figure 26. Global Morphine Sulphate Revenue Market Share by Sterility (2021-2026)
Figure 27. Morphine Sulphate Consumed in Acute Pain Management
Figure 28. Global Morphine Sulphate Market: Acute Pain Management (2021-2026) & (K Units)
Figure 29. Morphine Sulphate Consumed in Chronic Pain Management
Figure 30. Global Morphine Sulphate Market: Chronic Pain Management (2021-2026) & (K Units)
Figure 31. Global Morphine Sulphate Sale Market Share by Application (2025)
Figure 32. Global Morphine Sulphate Revenue Market Share by Application in 2025
Figure 33. Morphine Sulphate Sales by Company in 2025 (K Units)
Figure 34. Global Morphine Sulphate Sales Market Share by Company in 2025
Figure 35. Morphine Sulphate Revenue by Company in 2025 ($ millions)
Figure 36. Global Morphine Sulphate Revenue Market Share by Company in 2025
Figure 37. Global Morphine Sulphate Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Morphine Sulphate Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Morphine Sulphate Sales 2021-2026 (K Units)
Figure 40. Americas Morphine Sulphate Revenue 2021-2026 ($ millions)
Figure 41. APAC Morphine Sulphate Sales 2021-2026 (K Units)
Figure 42. APAC Morphine Sulphate Revenue 2021-2026 ($ millions)
Figure 43. Europe Morphine Sulphate Sales 2021-2026 (K Units)
Figure 44. Europe Morphine Sulphate Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Morphine Sulphate Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Morphine Sulphate Revenue 2021-2026 ($ millions)
Figure 47. Americas Morphine Sulphate Sales Market Share by Country in 2025
Figure 48. Americas Morphine Sulphate Revenue Market Share by Country (2021-2026)
Figure 49. Americas Morphine Sulphate Sales Market Share by Type (2021-2026)
Figure 50. Americas Morphine Sulphate Sales Market Share by Application (2021-2026)
Figure 51. United States Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Morphine Sulphate Sales Market Share by Region in 2025
Figure 56. APAC Morphine Sulphate Revenue Market Share by Region (2021-2026)
Figure 57. APAC Morphine Sulphate Sales Market Share by Type (2021-2026)
Figure 58. APAC Morphine Sulphate Sales Market Share by Application (2021-2026)
Figure 59. China Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 63. India Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Morphine Sulphate Sales Market Share by Country in 2025
Figure 67. Europe Morphine Sulphate Revenue Market Share by Country (2021-2026)
Figure 68. Europe Morphine Sulphate Sales Market Share by Type (2021-2026)
Figure 69. Europe Morphine Sulphate Sales Market Share by Application (2021-2026)
Figure 70. Germany Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 71. France Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Morphine Sulphate Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Morphine Sulphate Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Morphine Sulphate Sales Market Share by Application (2021-2026)
Figure 78. Egypt Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Morphine Sulphate in 2026
Figure 84. Manufacturing Process Analysis of Morphine Sulphate
Figure 85. Industry Chain Structure of Morphine Sulphate
Figure 86. Channels of Distribution
Figure 87. Global Morphine Sulphate Sales Market Forecast by Region (2027-2032)
Figure 88. Global Morphine Sulphate Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Morphine Sulphate Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Morphine Sulphate Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Morphine Sulphate Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Morphine Sulphate Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Morphine Sulphate
Figure 2. Morphine Sulphate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Morphine Sulphate Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Morphine Sulphate Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Morphine Sulphate Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Morphine Sulphate Sales Market Share by Country/Region (2025)
Figure 10. Morphine Sulphate Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immediate-Release (IR)
Figure 12. Product Picture of Controlled-Release (CR)
Figure 13. Product Picture of Sustained-Release (SR)
Figure 14. Global Morphine Sulphate Sales Market Share by Type in 2026
Figure 15. Global Morphine Sulphate Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of <15 mg
Figure 17. Product Picture of 15–30 mg
Figure 18. Product Picture of 30–60 mg
Figure 19. Product Picture of 60–100 mg
Figure 20. Product Picture of >100 mg
Figure 21. Global Morphine Sulphate Sales Market Share by Strength in 2026
Figure 22. Global Morphine Sulphate Revenue Market Share by Strength (2021-2026)
Figure 23. Product Picture of Sterile Injectable Grade
Figure 24. Product Picture of Non-Sterile Oral Grade
Figure 25. Global Morphine Sulphate Sales Market Share by Sterility in 2026
Figure 26. Global Morphine Sulphate Revenue Market Share by Sterility (2021-2026)
Figure 27. Morphine Sulphate Consumed in Acute Pain Management
Figure 28. Global Morphine Sulphate Market: Acute Pain Management (2021-2026) & (K Units)
Figure 29. Morphine Sulphate Consumed in Chronic Pain Management
Figure 30. Global Morphine Sulphate Market: Chronic Pain Management (2021-2026) & (K Units)
Figure 31. Global Morphine Sulphate Sale Market Share by Application (2025)
Figure 32. Global Morphine Sulphate Revenue Market Share by Application in 2025
Figure 33. Morphine Sulphate Sales by Company in 2025 (K Units)
Figure 34. Global Morphine Sulphate Sales Market Share by Company in 2025
Figure 35. Morphine Sulphate Revenue by Company in 2025 ($ millions)
Figure 36. Global Morphine Sulphate Revenue Market Share by Company in 2025
Figure 37. Global Morphine Sulphate Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Morphine Sulphate Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Morphine Sulphate Sales 2021-2026 (K Units)
Figure 40. Americas Morphine Sulphate Revenue 2021-2026 ($ millions)
Figure 41. APAC Morphine Sulphate Sales 2021-2026 (K Units)
Figure 42. APAC Morphine Sulphate Revenue 2021-2026 ($ millions)
Figure 43. Europe Morphine Sulphate Sales 2021-2026 (K Units)
Figure 44. Europe Morphine Sulphate Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Morphine Sulphate Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Morphine Sulphate Revenue 2021-2026 ($ millions)
Figure 47. Americas Morphine Sulphate Sales Market Share by Country in 2025
Figure 48. Americas Morphine Sulphate Revenue Market Share by Country (2021-2026)
Figure 49. Americas Morphine Sulphate Sales Market Share by Type (2021-2026)
Figure 50. Americas Morphine Sulphate Sales Market Share by Application (2021-2026)
Figure 51. United States Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Morphine Sulphate Sales Market Share by Region in 2025
Figure 56. APAC Morphine Sulphate Revenue Market Share by Region (2021-2026)
Figure 57. APAC Morphine Sulphate Sales Market Share by Type (2021-2026)
Figure 58. APAC Morphine Sulphate Sales Market Share by Application (2021-2026)
Figure 59. China Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 63. India Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Morphine Sulphate Sales Market Share by Country in 2025
Figure 67. Europe Morphine Sulphate Revenue Market Share by Country (2021-2026)
Figure 68. Europe Morphine Sulphate Sales Market Share by Type (2021-2026)
Figure 69. Europe Morphine Sulphate Sales Market Share by Application (2021-2026)
Figure 70. Germany Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 71. France Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Morphine Sulphate Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Morphine Sulphate Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Morphine Sulphate Sales Market Share by Application (2021-2026)
Figure 78. Egypt Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Morphine Sulphate Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Morphine Sulphate in 2026
Figure 84. Manufacturing Process Analysis of Morphine Sulphate
Figure 85. Industry Chain Structure of Morphine Sulphate
Figure 86. Channels of Distribution
Figure 87. Global Morphine Sulphate Sales Market Forecast by Region (2027-2032)
Figure 88. Global Morphine Sulphate Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Morphine Sulphate Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Morphine Sulphate Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Morphine Sulphate Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Morphine Sulphate Revenue Market Share Forecast by Application (2027-2032)
